IBDEI0PF ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11424,0)
;;=93784^^45^548^2^^^^1
;;^UTILITY(U,$J,358.3,11424,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11424,1,2,0)
;;=2^Amb BP Monitor 24+ hrs,Intrp & Rpt
;;^UTILITY(U,$J,358.3,11424,1,3,0)
;;=3^93784
;;^UTILITY(U,$J,358.3,11425,0)
;;=93786^^45^548^3^^^^1
;;^UTILITY(U,$J,358.3,11425,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11425,1,2,0)
;;=2^Amb BP Monitor 24+ hrs,Rpt Only
;;^UTILITY(U,$J,358.3,11425,1,3,0)
;;=3^93786
;;^UTILITY(U,$J,358.3,11426,0)
;;=93788^^45^548^1^^^^1
;;^UTILITY(U,$J,358.3,11426,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11426,1,2,0)
;;=2^Amb BP Analysis & Rpt
;;^UTILITY(U,$J,358.3,11426,1,3,0)
;;=3^93788
;;^UTILITY(U,$J,358.3,11427,0)
;;=93790^^45^548^4^^^^1
;;^UTILITY(U,$J,358.3,11427,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11427,1,2,0)
;;=2^Amb BP Review,Intrp & Rpt
;;^UTILITY(U,$J,358.3,11427,1,3,0)
;;=3^93790
;;^UTILITY(U,$J,358.3,11428,0)
;;=93770^^45^548^5^^^^1
;;^UTILITY(U,$J,358.3,11428,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11428,1,2,0)
;;=2^Measure Venous Pressure
;;^UTILITY(U,$J,358.3,11428,1,3,0)
;;=3^93770
;;^UTILITY(U,$J,358.3,11429,0)
;;=J0636^^45^549^1^^^^1
;;^UTILITY(U,$J,358.3,11429,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11429,1,2,0)
;;=2^Calcitriol per 0.1 MCG
;;^UTILITY(U,$J,358.3,11429,1,3,0)
;;=3^J0636
;;^UTILITY(U,$J,358.3,11430,0)
;;=J0713^^45^549^2^^^^1
;;^UTILITY(U,$J,358.3,11430,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11430,1,2,0)
;;=2^Ceftazidime per 500 MG
;;^UTILITY(U,$J,358.3,11430,1,3,0)
;;=3^J0713
;;^UTILITY(U,$J,358.3,11431,0)
;;=J1160^^45^549^5^^^^1
;;^UTILITY(U,$J,358.3,11431,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11431,1,2,0)
;;=2^Digoxin up to 0.5 MG
;;^UTILITY(U,$J,358.3,11431,1,3,0)
;;=3^J1160
;;^UTILITY(U,$J,358.3,11432,0)
;;=Q0138^^45^549^9^^^^1
;;^UTILITY(U,$J,358.3,11432,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11432,1,2,0)
;;=2^Ferumoxytol,Non-ESRD,1 MG
;;^UTILITY(U,$J,358.3,11432,1,3,0)
;;=3^Q0138
;;^UTILITY(U,$J,358.3,11433,0)
;;=Q0139^^45^549^8^^^^1
;;^UTILITY(U,$J,358.3,11433,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11433,1,2,0)
;;=2^Ferumoxytol,ESRD Use,1 MG
;;^UTILITY(U,$J,358.3,11433,1,3,0)
;;=3^Q0139
;;^UTILITY(U,$J,358.3,11434,0)
;;=J1580^^45^549^10^^^^1
;;^UTILITY(U,$J,358.3,11434,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11434,1,2,0)
;;=2^Garamycin Gentamicin up to 80 MG
;;^UTILITY(U,$J,358.3,11434,1,3,0)
;;=3^J1580
;;^UTILITY(U,$J,358.3,11435,0)
;;=J1644^^45^549^12^^^^1
;;^UTILITY(U,$J,358.3,11435,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11435,1,2,0)
;;=2^Heparin Sodium per 1000 Units
;;^UTILITY(U,$J,358.3,11435,1,3,0)
;;=3^J1644
;;^UTILITY(U,$J,358.3,11436,0)
;;=96374^^45^549^13^^^^1
;;^UTILITY(U,$J,358.3,11436,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11436,1,2,0)
;;=2^IV Push,Ther/Proph/Diag
;;^UTILITY(U,$J,358.3,11436,1,3,0)
;;=3^96374
;;^UTILITY(U,$J,358.3,11437,0)
;;=J1750^^45^549^14^^^^1
;;^UTILITY(U,$J,358.3,11437,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11437,1,2,0)
;;=2^Iron Dextran 50 MG
;;^UTILITY(U,$J,358.3,11437,1,3,0)
;;=3^J1750
;;^UTILITY(U,$J,358.3,11438,0)
;;=B4189^^45^549^15^^^^1
;;^UTILITY(U,$J,358.3,11438,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11438,1,2,0)
;;=2^Parenteral NutrSol 10-51 g Protein
;;^UTILITY(U,$J,358.3,11438,1,3,0)
;;=3^B4189
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0PF 3765 printed Sep 23, 2025@19:29:11 Page 2
IBDEI0PF ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11424,0)
+2 ;;=93784^^45^548^2^^^^1
+3 ;;^UTILITY(U,$J,358.3,11424,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,11424,1,2,0)
+6 ;;=2^Amb BP Monitor 24+ hrs,Intrp & Rpt
+7 ;;^UTILITY(U,$J,358.3,11424,1,3,0)
+8 ;;=3^93784
+9 ;;^UTILITY(U,$J,358.3,11425,0)
+10 ;;=93786^^45^548^3^^^^1
+11 ;;^UTILITY(U,$J,358.3,11425,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,11425,1,2,0)
+14 ;;=2^Amb BP Monitor 24+ hrs,Rpt Only
+15 ;;^UTILITY(U,$J,358.3,11425,1,3,0)
+16 ;;=3^93786
+17 ;;^UTILITY(U,$J,358.3,11426,0)
+18 ;;=93788^^45^548^1^^^^1
+19 ;;^UTILITY(U,$J,358.3,11426,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,11426,1,2,0)
+22 ;;=2^Amb BP Analysis & Rpt
+23 ;;^UTILITY(U,$J,358.3,11426,1,3,0)
+24 ;;=3^93788
+25 ;;^UTILITY(U,$J,358.3,11427,0)
+26 ;;=93790^^45^548^4^^^^1
+27 ;;^UTILITY(U,$J,358.3,11427,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,11427,1,2,0)
+30 ;;=2^Amb BP Review,Intrp & Rpt
+31 ;;^UTILITY(U,$J,358.3,11427,1,3,0)
+32 ;;=3^93790
+33 ;;^UTILITY(U,$J,358.3,11428,0)
+34 ;;=93770^^45^548^5^^^^1
+35 ;;^UTILITY(U,$J,358.3,11428,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,11428,1,2,0)
+38 ;;=2^Measure Venous Pressure
+39 ;;^UTILITY(U,$J,358.3,11428,1,3,0)
+40 ;;=3^93770
+41 ;;^UTILITY(U,$J,358.3,11429,0)
+42 ;;=J0636^^45^549^1^^^^1
+43 ;;^UTILITY(U,$J,358.3,11429,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,11429,1,2,0)
+46 ;;=2^Calcitriol per 0.1 MCG
+47 ;;^UTILITY(U,$J,358.3,11429,1,3,0)
+48 ;;=3^J0636
+49 ;;^UTILITY(U,$J,358.3,11430,0)
+50 ;;=J0713^^45^549^2^^^^1
+51 ;;^UTILITY(U,$J,358.3,11430,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,11430,1,2,0)
+54 ;;=2^Ceftazidime per 500 MG
+55 ;;^UTILITY(U,$J,358.3,11430,1,3,0)
+56 ;;=3^J0713
+57 ;;^UTILITY(U,$J,358.3,11431,0)
+58 ;;=J1160^^45^549^5^^^^1
+59 ;;^UTILITY(U,$J,358.3,11431,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,11431,1,2,0)
+62 ;;=2^Digoxin up to 0.5 MG
+63 ;;^UTILITY(U,$J,358.3,11431,1,3,0)
+64 ;;=3^J1160
+65 ;;^UTILITY(U,$J,358.3,11432,0)
+66 ;;=Q0138^^45^549^9^^^^1
+67 ;;^UTILITY(U,$J,358.3,11432,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,11432,1,2,0)
+70 ;;=2^Ferumoxytol,Non-ESRD,1 MG
+71 ;;^UTILITY(U,$J,358.3,11432,1,3,0)
+72 ;;=3^Q0138
+73 ;;^UTILITY(U,$J,358.3,11433,0)
+74 ;;=Q0139^^45^549^8^^^^1
+75 ;;^UTILITY(U,$J,358.3,11433,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,11433,1,2,0)
+78 ;;=2^Ferumoxytol,ESRD Use,1 MG
+79 ;;^UTILITY(U,$J,358.3,11433,1,3,0)
+80 ;;=3^Q0139
+81 ;;^UTILITY(U,$J,358.3,11434,0)
+82 ;;=J1580^^45^549^10^^^^1
+83 ;;^UTILITY(U,$J,358.3,11434,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,11434,1,2,0)
+86 ;;=2^Garamycin Gentamicin up to 80 MG
+87 ;;^UTILITY(U,$J,358.3,11434,1,3,0)
+88 ;;=3^J1580
+89 ;;^UTILITY(U,$J,358.3,11435,0)
+90 ;;=J1644^^45^549^12^^^^1
+91 ;;^UTILITY(U,$J,358.3,11435,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,11435,1,2,0)
+94 ;;=2^Heparin Sodium per 1000 Units
+95 ;;^UTILITY(U,$J,358.3,11435,1,3,0)
+96 ;;=3^J1644
+97 ;;^UTILITY(U,$J,358.3,11436,0)
+98 ;;=96374^^45^549^13^^^^1
+99 ;;^UTILITY(U,$J,358.3,11436,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,11436,1,2,0)
+102 ;;=2^IV Push,Ther/Proph/Diag
+103 ;;^UTILITY(U,$J,358.3,11436,1,3,0)
+104 ;;=3^96374
+105 ;;^UTILITY(U,$J,358.3,11437,0)
+106 ;;=J1750^^45^549^14^^^^1
+107 ;;^UTILITY(U,$J,358.3,11437,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,11437,1,2,0)
+110 ;;=2^Iron Dextran 50 MG
+111 ;;^UTILITY(U,$J,358.3,11437,1,3,0)
+112 ;;=3^J1750
+113 ;;^UTILITY(U,$J,358.3,11438,0)
+114 ;;=B4189^^45^549^15^^^^1
+115 ;;^UTILITY(U,$J,358.3,11438,1,0)
+116 ;;=^358.31IA^3^2
+117 ;;^UTILITY(U,$J,358.3,11438,1,2,0)
+118 ;;=2^Parenteral NutrSol 10-51 g Protein
+119 ;;^UTILITY(U,$J,358.3,11438,1,3,0)
+120 ;;=3^B4189
